Strata Critical Medical Files 8-K/A Amendment
Ticker: SRTAW · Form: 8-K/A · Filed: Aug 29, 2025 · CIK: 1779128
| Field | Detail |
|---|---|
| Company | Strata Critical Medical, Inc. (SRTAW) |
| Form Type | 8-K/A |
| Filed Date | Aug 29, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001, $11.50, $550,000, $500,000, $2,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, leadership-change, financial-statements
TL;DR
Strata Critical Medical amended its 8-K filing, updating leadership and financial info as of Aug 1, 2025.
AI Summary
Strata Critical Medical, Inc. filed an 8-K/A amendment on August 29, 2025, reporting events as of August 1, 2025. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes financial statements and exhibits.
Why It Matters
This amendment provides updated information regarding the company's leadership and financial disclosures, which is crucial for investors to understand the company's governance and financial health.
Risk Assessment
Risk Level: low — This is a routine amendment filing that updates information rather than announcing a significant new event.
Key Players & Entities
- Strata Critical Medical, Inc. (company) — Registrant
- Blade Air Mobility, Inc. (company) — Former Company Name
- Experience Investment Corp. (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K/A filing?
The primary purpose is to amend a previous 8-K filing to report on the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements, and to include financial statements and exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is August 1, 2025.
What were the previous names of Strata Critical Medical, Inc.?
The company was formerly known as Blade Air Mobility, Inc. and Experience Investment Corp.
When did the company change its name from Blade Air Mobility, Inc.?
The company changed its name from Blade Air Mobility, Inc. on May 7, 2021.
What is the business address of Strata Critical Medical, Inc.?
The business address is 31 Hudson Yards, 14th Floor, New York, NY 10001.
Filing Stats: 1,204 words · 5 min read · ~4 pages · Grade level 11.5 · Accepted 2025-08-29 08:29:50
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SRTA The Nasdaq Stock Mar
- $11.50 — one share of Common Stock at a price of $11.50 SRTAW The Nasdaq Stock Market Ind
- $550,000 — Mr. Heyburn's respective base salary to $550,000, and (ii) the grant of certain performa
- $500,000 — s with a target grant date value of (i) $500,000 that will vest based on the attainment
- $2,000,000 — he 12 months following Closing and (ii) $2,000,000 that will vest based on the achievement
Filing Documents
- tm2524340d1_8ka.htm (8-K/A) — 33KB
- tm2524340d1_ex10-1.htm (EX-10.1) — 53KB
- tm2524340d1_ex10-2.htm (EX-10.2) — 69KB
- tm2524340d1_ex10-3.htm (EX-10.3) — 124KB
- tm2524340d1_ex10-4.htm (EX-10.4) — 124KB
- 0001104659-25-085182.txt ( ) — 713KB
- srta-20250801.xsd (EX-101.SCH) — 3KB
- srta-20250801_def.xml (EX-101.DEF) — 27KB
- srta-20250801_lab.xml (EX-101.LAB) — 36KB
- srta-20250801_pre.xml (EX-101.PRE) — 25KB
- tm2524340d1_8ka_htm.xml (XML) — 5KB
02 Departure of Directors or Certain
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously announced, effective as of the consummation of the transactions contemplated by that certain Equity Purchase Agreement, dated as of August 1, 2025, among the Company and the other parties thereto (the "Closing"), Melissa Tomkiel, who previously served as the Company's President and General Counsel, and William Heyburn, who previously served as the Company's Chief Financial Officer and Head of Corporate Development, assumed the roles of Co-Chief Executive Officers of the Company. Ms. Tomkiel will continue to also serve as the Company's General Counsel and Mr. Heyburn will continue to also serve as the Company's Chief Financial Officer. The duties formerly assigned to the President of the Company will be shared between Ms. Tomkiel and Mr. Heyburn. Co-Chief Executive Officer Compensation On August 27, 2025, the Board of Directors of the Company (the "Board"), upon the recommendation of the Compensation Committee of the Board, approved, effective as of the Closing, (i) an increase of Ms. Tomkiel's and Mr. Heyburn's respective base salary to $550,000, and (ii) the grant of certain performance-based restricted stock units ("PSUs") to Ms. Tomkiel and Mr. Heyburn under the Company's 2021 Omnibus Incentive Plan. Each of Ms. Tomkiel and Mr. Heyburn will receive PSUs with a target grant date value of (i) $500,000 that will vest based on the attainment by the Passenger business of certain financial targets during the 12 months following Closing and (ii) $2,000,000 that will vest based on the achievement by the Company of certain financial performance metrics over a three-year performance period. The foregoing summary of the terms of the PSUs does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the forms of PSUs which are filed as Exhibits 10.1 and 10.2 to t
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) The following exhibits are being filed herewith: Exhibit No. Description 10.1* Form of PSU Agreement (EBITDA Earnout) 10.2* Form of PSU Agreement (2025 Co-CEO) 10.3* Co-CEO Offer Letter with Melissa Tomkiel, dated August 28, 2025 10.4* Co-CEO Offer Letter with William Heyburn, dated August 28, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Denotes a management contract or compensatory arrangement SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STRATA CRITICAL MEDICAL, INC. Dated: August 29, 2025 By: /s/ William A. Heyburn Name: William A. Heyburn Title: Co-Chief Executive Officer and Chief Financial Officer